Two-hybrid technology has contributed significantly to the unraveling
of molecular regulatory networks by facilitating the discovery of prot
ein interactions, Outgrowths of these methods are developing rapidly,
including interaction mating to identify false positives and map prote
in networks, two-bait systems, systems not based on transcription, and
systems permitting the selection of peptide aptamers to manipulate ge
ne and allele function. These advances promise to have a significant i
mpact on industrial biotechnology and drug development.